Company / CapEx per Share
BridgeBio Pharma, Inc. CapEx per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.09
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#139 of 192
Health Care
What the data says
At $0.01, BridgeBio Pharma, Inc.'s capex per share ranks #139 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 9 years, ranging from $0.01 in FY2024 to $0.09 in FY2023.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -37.6%.
Declined from $0.09 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -43.9%
- 5-Year CAGR
- -37.6%
- 10-Year CAGR
- -
Sector benchmark
#139 of 192 in Health CareTop 72% of 192This company $0.01 Sector average $2.46
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 8.3% year-over-year.
- Ranks #139 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +8.3% |
| FY2024 | $0.01 | -93.9% |
| FY2023 | $0.09 | +168.8% |
| FY2022 | $0.03 | +52.4% |
| FY2021 | $0.02 | -64.7% |
| FY2020 | $0.06 | +112.2% |
| FY2019 | $0.03 | -18.7% |
| FY2018 | $0.04 | +132.5% |
| FY2017 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026